The T–P network indicated that the targets of these drugs were involved in different pathways, such as neuroactive ligand–receptor interactions, calcium signaling, steroid hormone biosynthesis, peroxisome proliferator-activated receptor (PPAR) signaling, cancer, and vascular smooth muscle contraction. This evidence concerns the gene PPARA and cancer.